hepat
b
viru
hbv
infect
remain
signific
health
threat
human
lead
elev
rate
sever
liver
diseas
fulmin
hepat
fibrosi
cirrhosi
primari
hepatocellular
carcinoma
clinic
complic
hbv
prototyp
member
hepadnavirida
famili
contain
number
dna
virus
replic
genom
revers
transcript
viral
rna
intermedi
hepatocyt
cell
infect
mediat
viral
receptor
call
sodium
taurochol
cotransport
polypeptid
ntcp
relax
circular
rc
viral
dna
genom
virion
enter
nucleu
transform
nucleosomedecor
coval
close
circular
ccc
dna
minichromosom
use
cccdna
transcript
templat
five
viral
mrna
transcrib
differ
transcript
initi
site
termin
polyadenyl
site
kb
precor
mrna
kb
pregenom
pg
rna
kb
surfac
envelop
mrna
x
mrna
besid
serv
templat
translat
viral
core
protein
polymeras
pol
pgrna
also
templat
revers
transcript
pol
recogn
stem
loop
structur
epsilon
terminu
pgrna
recruit
core
protein
encapsid
polpgrna
complex
nucleocapsid
revers
transcript
take
place
yield
progeni
viral
rcdna
consid
import
viral
rna
hbv
life
cycl
conceiv
hbv
rna
reduct
result
suppress
viral
dna
replic
antigen
product
therefor
hijack
hbv
rna
believ
import
antivir
strategi
host
defens
hbv
line
interferon
abl
directli
reduc
hbv
rna
transcript
posttranscript
mechan
term
interferonstimul
gene
isg
tripartit
motifcontain
protein
deadbox
rna
helicas
shown
inhibit
hbv
rna
transcript
zinc
finger
antivir
protein
zap
myeloid
differenti
primari
respons
gene
identifi
host
intrins
antivir
factor
hbv
promot
decay
hbv
rna
search
isg
inhibit
hbv
replic
previous
found
kda
interferonstimul
gene
product
refer
inhibit
hbv
replic
primarili
reduc
hbv
rna
transcript
level
cell
cultur
protein
shown
induc
type
type
ii
ifn
belong
deddh
subgroup
dedd
exonucleas
superfamili
sequenc
homolog
distribut
three
distinct
motif
term
exoi
exoii
aa
exoiii
aa
exonucleas
substrat
prefer
singlestrand
rna
doublestrand
rna
singlestrand
dna
enzymat
activ
mediat
exoii
motif
substitut
aspart
acid
exoii
motif
glycin
complet
abolish
exonucleas
activ
cellular
protein
may
involv
regul
substrat
recognit
andor
bind
order
avoid
nonspecif
cell
toxic
howev
remain
identifi
shown
play
import
role
host
antivir
innat
immun
defens
key
isg
alphaviru
replic
host
antivir
defens
mediat
via
signal
cell
overexpress
resist
infect
rna
virus
includ
vesicular
stomat
viru
vsv
influenza
viru
encephalomyocard
viru
emcv
hepat
c
viru
hav
hcv
yellow
fever
viru
hiv
dna
viru
adenoviru
context
hbv
infect
report
highli
induc
ifnmedi
suppress
viral
replic
hbv
transgen
mous
hepatocyt
cell
line
liver
acut
hbv
infect
chimpanze
viral
clearanc
phase
interestingli
chronic
hepat
b
patient
good
respons
ifn
treatment
show
significantli
higher
level
liver
compar
either
patient
nonrespond
ifn
treatment
healthi
control
find
suggest
may
play
role
suppress
hbv
respons
host
immun
activ
ifnbas
immunotherapi
therefor
set
character
antivir
function
mechan
innat
control
hbv
report
herein
endogen
restrict
factor
hbv
replic
upregul
three
type
ifn
inhibit
hbv
inhibit
hbv
replic
primarili
promot
viral
rna
degrad
hbv
rna
degrad
depend
ribonucleas
activ
enzymat
inactiv
form
retain
antivir
activ
pgrna
encapsid
compet
hbv
pol
pgrna
bind
recogn
hbv
rna
directli
bind
lower
stem
region
epsilon
bind
domain
locat
exo
iii
motif
bind
essenti
hbv
rna
degrad
cell
cultur
cofactor
may
requir
effici
degrad
stemloop
region
hbv
rna
result
thu
impact
better
understand
biolog
hostviru
interact
may
provid
basi
host
ribonucleasebas
antivir
develop
interferon
induc
protein
firstli
assess
basal
express
cell
cultur
induc
ifn
use
hela
cell
posit
control
basal
level
express
detect
cell
cell
western
blot
express
significantli
upregul
stimul
fig
furthermor
highli
induc
three
type
ifn
cell
primari
human
hepatocyt
phh
fig
accord
previou
studi
transcript
regul
uniqu
interferon
stimul
respons
element
isr
tataless
human
promot
confer
constitut
transcript
activ
gene
respons
type
ii
interferon
basal
cytokineinduc
express
intrahepat
indic
potenti
import
role
host
defens
mechan
pathogen
infect
hepatocyt
effort
determin
antivir
activ
hbv
replic
hepatocyt
flagtag
wild
type
cotransfect
hbv
precor
mrna
pgrna
transcript
control
viral
enhanc
ii
core
promot
eniicp
pcmvhbv
pgrna
transcript
govern
cmvie
promot
cell
hbv
viral
rna
dna
analyz
shown
fig
result
clearli
demonstr
markedli
inhibit
hbv
dna
replic
middl
panel
primarili
reduc
steadi
state
level
viral
pgrna
top
panel
templat
hbv
dna
synthesi
effect
independ
promot
hbv
eniicp
cmvie
use
transcrib
pgrna
similar
antivir
effect
also
observ
cell
fig
furthermor
pgrna
reduct
dose
depend
fig
due
possibl
cytotox
effect
caus
overexpress
fig
addit
along
pgrna
reduct
level
kb
kb
hbv
surfac
mrna
share
sequenc
ident
portion
pgrna
also
reduc
upon
express
fig
top
panel
reduct
hbv
kb
rna
confirm
cotransfect
plasmid
plm
express
hbv
subgenom
surfac
mrna
cell
fig
consist
reduct
kb
kb
hbv
rna
level
supernat
hbeag
hbsag
also
significantli
decreas
fig
consid
hbv
plasmid
dna
viral
transcript
templat
transfect
system
possibl
reduc
hbv
rna
destabil
transfect
hbv
plasmid
dna
block
nuclear
import
input
plasmid
test
possibl
recov
hbv
plasmid
dna
transfect
cell
hirt
dna
extract
follow
dpn
digest
southern
blot
analysi
result
show
level
input
hbv
plasmid
dna
recov
whole
cell
equal
absenc
presenc
reveal
dpn
idigest
fragment
fig
top
panel
furthermor
overexpress
reduc
hbv
core
dna
replic
cytoplasm
affect
level
remain
cytoplasm
hbv
plasmid
dna
fig
middl
panel
confirm
alter
stabil
distribut
input
hbv
plasmid
addit
transfect
hbv
stabl
cell
line
cell
also
result
reduct
hbv
rna
transcrib
integr
hbv
dna
fig
collect
result
clearli
exclud
neg
effect
stabil
hbv
rna
transcript
templat
consist
report
inabl
degrad
doubl
strand
dna
substrat
vitro
next
order
determin
whether
downregul
hbv
rna
via
transcript
posttranscript
mechan
first
assess
potenti
effect
viral
promot
activ
shown
fig
luciferas
report
assay
demonstr
significantli
affect
activ
hbv
enhanc
iicor
eniicp
promot
promot
cmvie
promot
even
enhanc
hbv
promot
activ
therefor
unlik
reduc
hbv
rna
inhibit
viral
promot
activ
transcript
level
compar
decay
kinet
hbv
rna
absenc
presenc
overexpress
briefli
express
vector
control
empti
vector
transfect
induc
hbv
stabl
cell
line
cell
absenc
tetracyclin
tet
induc
hbv
pgrna
transcript
express
h
later
tet
ad
back
shut
de
novo
pgrna
transcript
transgen
level
hbv
rna
differ
time
point
analyz
northern
blot
fig
repres
northern
blot
demonstr
level
hbv
rna
cell
overexpress
time
point
less
control
group
suggest
promot
hbv
rna
degrad
consist
previou
observ
function
riboexonucleas
degrad
singlestrand
viral
rna
genom
worth
note
everi
hbv
rnacontain
cell
transfect
therefor
actual
effect
hbv
rna
stabil
ought
stronger
observ
experi
quantit
valid
observ
enhanc
hbv
rna
degrad
transfect
cell
tetracyclineinduc
hbv
express
vector
ptrehbvd
plasmid
ptetoff
express
tetracyclinerespons
transcript
activ
tta
togeth
either
control
vector
plasmid
way
hbv
rna
coexist
cell
four
day
later
similarli
experi
cell
tetracyclin
ad
back
block
new
round
pgrna
transcript
time
cours
hbv
rna
level
quantifi
qpcr
shown
fig
regular
halflif
intracellular
hbv
rna
approxim
h
consist
previou
measur
decay
kinet
hbv
rna
much
faster
cell
transfect
hbv
rna
halflif
much
less
h
suggest
promot
hbv
rna
decay
henc
conclud
hbv
rna
reduct
primarili
downregul
hbv
rna
stabil
basal
level
express
hepatocyt
could
induc
interferon
fig
therefor
interest
assess
antivir
activ
endogen
hbv
infect
basal
induc
level
firstli
perform
test
hbv
stabl
cell
line
shown
fig
knock
express
absenc
treatment
result
mark
upregul
steadi
state
level
hbv
total
rna
encapsid
pgrna
dna
compar
lane
lane
l
observ
rel
greater
upregul
core
dna
viral
rna
upon
knock
might
due
longer
lifespan
dna
cell
treat
upregul
viral
rna
dna
reduc
ifn
dosedepend
manner
lane
worth
note
ifnelicit
reduct
hbv
rna
cell
less
profound
hbvtransfect
cell
overexpress
compar
fig
fig
differ
might
due
report
weak
respons
hepatoma
cell
ifn
treatment
andor
potenti
unknown
neg
regul
coinduc
ifn
nonetheless
cell
treat
sirna
level
hbv
rna
restor
untreat
control
level
compar
lane
lane
suggest
play
major
role
ifnmedi
reduct
hbv
rna
cell
howev
neither
viral
rna
dna
reach
level
cell
treat
sirna
compar
lane
lane
indic
isg
involv
ifnmedi
suppress
hbv
dna
replic
multipl
step
next
assess
antivir
function
hbv
vitro
infect
system
specif
viral
receptor
ntcp
reconstitut
cell
endogen
cell
stabli
inhibit
lentivir
shrna
transduct
obtain
knock
cell
line
control
knock
cell
line
infect
hbv
treat
without
shown
fig
basal
express
success
knock
cell
compar
lane
significantli
upregul
express
cell
compar
lane
slightli
induc
cell
compar
lane
outcom
hbv
infect
analyz
hbcag
immunofluoresc
stain
demonstr
knock
result
higher
percentag
hbv
posit
cell
compar
control
cell
without
treatment
fig
hbv
rna
degrad
lead
overal
suppress
entir
hbv
life
cycl
infect
system
infer
increas
percentag
core
stainingposit
cell
number
hbv
infect
cell
combin
end
effect
increas
viral
protein
express
dna
replic
cccdna
synthesi
plu
possibl
higher
viru
spread
rate
sinc
hbv
rna
convinc
marker
hbv
infect
authent
antivir
target
qpcr
assay
hbv
total
rna
infect
cell
demonstr
abl
reduc
hbv
rna
infect
cell
knock
greatli
favor
hbv
infect
ifntreat
untreat
cell
fig
consist
observ
cell
fig
inhibit
significantli
partial
abrog
overal
antivir
activ
hbv
infect
cell
fig
presum
due
induct
antivir
isg
collect
data
suggest
serv
host
intrins
restrict
factor
limit
hbv
infect
basal
express
cytokin
induct
three
put
exonucleas
domain
report
singl
mutat
exo
ii
domain
complet
abolish
protein
enzymat
activ
vitro
line
found
enzymat
inact
mutant
fail
reduc
hbv
rna
cell
fig
top
panel
suggest
hbv
rna
decay
requir
exoribonucleas
activ
interestingli
although
level
total
viral
rna
capsid
remain
level
encapsid
hbv
pgrna
significantli
reduc
express
mutant
middl
panel
compar
lane
consequ
led
inhibit
viral
dna
replic
bottom
panel
inhibitori
effect
pgrna
encapsid
confirm
hbv
genom
harbor
polymeras
mutat
support
hbv
pgrna
bind
encapsid
dna
replic
fig
sinc
hbv
pgrna
encapsid
requir
dynam
interact
among
three
viral
compon
specif
pgrna
pol
core
protein
possibl
might
antagon
one
three
viral
factor
block
encapsid
howev
inhibit
capsid
assembl
fig
panel
top
hbv
rna
degrad
reli
viral
core
pol
protein
fig
base
data
hypothes
might
physic
bind
hbv
rna
degrad
thu
particular
case
associ
pgrna
inhibit
bind
hbv
polymeras
pgrna
subsequ
pgrna
encapsid
test
hypothesi
first
investig
associ
hbv
rna
cell
cultur
immunoprecipit
ip
northern
assay
fig
plasmid
support
hbv
rna
transcript
support
pgrna
encapsid
ci
due
delet
core
pol
express
use
hbv
rna
transcript
templat
flagtag
hbv
pol
flagpol
use
tran
posit
control
pgrna
bind
avoid
rapid
rna
degrad
mediat
wild
type
express
mutant
use
assay
upper
panel
fig
indic
input
hbv
rna
level
flagpol
protein
level
lower
panel
fig
show
northern
blot
result
ip
flag
antibodi
ab
expect
flagpol
interact
hbv
rna
flag
ab
ha
ab
could
pull
hbv
rna
flagpol
also
specif
form
complex
hbv
rna
ipnorthern
assay
suggest
interact
hbv
rna
cell
cultur
though
remain
unknown
whether
interact
direct
indirect
next
set
investig
potenti
competit
effect
polpgrna
bind
fix
amount
flagpol
cotransfect
cell
togeth
plasmid
express
hatag
titrat
manner
fig
show
input
hbv
rna
flagpol
protein
level
upper
panel
immunoprecipit
hbv
rna
level
ha
flag
ab
pulldown
lower
panel
ha
ab
ipnorthern
result
demonstr
bound
hbv
rna
dose
depend
manner
contrast
increas
amount
result
decreas
amount
hbv
rna
associ
pol
suggest
compet
hbv
pol
bind
pgrna
thu
inhibit
hbv
pgrna
encapsid
assum
wildtyp
may
possess
addit
antivir
function
cell
inhibit
pgrna
encapsid
like
overwhelm
domin
primari
effect
rna
degrad
data
demonstr
interact
hbv
rna
order
map
sequenc
made
use
seri
intern
delet
clone
termin
delet
clone
hbv
rna
genom
express
truncat
rna
sensit
rna
degrad
assess
fig
fig
firstli
found
pgrna
mutant
intern
delet
within
nt
sensit
fig
termin
redund
tr
nt
contain
nt
mutant
delet
either
tr
tr
pgrna
test
interestingli
singl
tr
delet
pgrna
remain
sensit
fig
lane
pgrna
mutant
tr
remov
becam
complet
resist
fig
lane
indic
one
copi
tr
sequenc
suffici
confer
suscept
hbv
pgrna
rna
degrad
also
consist
fact
also
abl
degrad
hbv
subgenom
rna
contain
tr
fig
fig
confirm
hbv
tr
respons
element
hbv
core
promot
activ
report
plasmid
eniicpluc
tr
region
insert
eniicptrluc
eniicpluctr
eniicptrluctr
nontransl
region
luciferas
gene
fig
transfect
cell
without
luciferas
activ
measur
result
demonstr
introduct
hbv
tr
luciferas
mrna
result
signific
reduct
luciferas
gene
express
express
fig
therefor
conclud
select
target
tr
sequenc
hbv
rna
initi
rna
degrad
hbv
pol
recogn
bind
stemloop
structur
tr
region
hbv
pgrna
call
epsilon
initi
pgrna
encapsid
revers
transcript
sinc
hbv
rna
degrad
reli
tr
sequenc
fig
compet
pol
hbv
rna
bind
fig
therefor
immedi
interest
investig
whether
also
directli
bind
hbv
exert
antivir
function
end
electrophoret
mobil
shift
assay
emsa
employ
shown
fig
purifi
recombin
histag
protein
incub
radiolabel
hbv
rna
vitro
proteinrna
complex
analyz
via
mobil
shift
rna
nativ
polyacrylamid
gel
proper
fold
stemloop
structur
rna
confirm
recombin
complex
format
detect
emsa
assay
fig
interestingli
absenc
cellular
protein
could
directli
dosedepend
bind
rna
shown
shift
band
fig
lane
bind
specif
confirm
hisantibodi
ab
supercomplex
format
detect
supershift
emsa
lane
competit
bind
radiolabel
rna
excess
amount
cold
probe
indic
specif
bind
hbv
lane
note
incub
rna
emsa
perform
proteinrna
bind
buffer
without
manganes
essenti
ion
enzymat
activ
therefor
degrad
rna
could
occur
would
observ
bind
assay
dissect
substructur
domain
target
synthet
upper
stemloop
rna
lower
stemloop
rna
mutant
shown
fig
radiolabel
use
gel
shift
assay
interestingli
bound
lower
stem
bulg
sequenc
serv
loop
upper
stemloop
emsa
fig
indic
recogn
lower
stem
andor
bulg
hbv
bind
site
determin
bind
posit
within
lower
stem
bulg
region
bulg
sequenc
mutat
lower
stem
truncat
bottom
fig
use
probe
emsa
interestingli
found
loop
bulg
sequenc
critic
bind
long
lower
stem
intact
howev
bottom
basepair
stem
indispens
bind
fig
confirm
requir
basepair
carri
biolog
function
disrupt
base
pair
bottom
stemloop
hbv
kb
surfac
mrna
remov
nucleotid
end
code
sequenc
found
mutant
rna
becam
resist
rna
degrad
cell
cultur
fig
collect
find
impli
recogn
sequencespecif
secondari
structur
hbv
rna
bind
degrad
sinc
abl
bind
rna
substrat
directli
absenc
cellular
viral
protein
therefor
interest
investig
domain
respons
rna
bind
three
distinct
exonucleas
motif
name
exo
exo
ii
aa
exo
iii
aa
predict
protein
sequenc
previou
studi
fig
base
recombin
mutant
protein
exo
domain
delet
exo
ii
mutat
test
bind
activ
emsa
shown
fig
comparison
wildtyp
delet
exo
exo
ii
reduc
even
increas
bind
affin
lane
howev
exo
iii
delet
complet
lost
bind
activ
lane
indic
exo
iii
function
bind
domain
rna
substrat
addit
enzymat
inact
mutant
retain
function
bind
lane
consist
observ
associ
hbv
rna
subsequ
inhibit
pgrna
encapsid
cell
fig
worth
note
ii
delet
mutant
well
mutant
exhibit
alter
mobil
compar
wildtyp
gel
shift
assay
fig
lane
vs
lane
predict
faster
mobil
ii
complex
like
due
protein
lower
molecular
weight
mw
lower
shift
complex
probabl
rnp
complex
exhibit
differ
structur
conform
compar
complex
confirm
function
exo
iii
domain
activ
flagtag
protein
delet
exo
iii
domain
express
hbv
transfect
cell
shown
fig
wildtyp
significantli
reduc
hbv
rna
level
expect
mutant
similar
ineffici
reduct
hbv
rna
therefor
conclud
requir
exo
ii
domain
enzymat
activ
separ
exo
iii
domain
respons
rna
substrat
bind
prerequisit
rna
degrad
lastli
set
character
enzymat
activ
rna
vitro
previou
biochemistri
studi
demonstr
catalyz
rna
degrad
vitro
manganesedepend
manner
shown
fig
reaction
condit
support
ribonucleas
activ
wide
spectrum
endoribonucleas
rnase
effici
degrad
rna
posit
control
panel
b
lane
howev
exhibit
much
less
effici
degrad
full
length
rna
substrat
panel
b
lane
two
stemloop
subdomain
usl
lsb
panel
lane
suggest
alon
favor
rna
secondari
structur
degrad
observ
consist
previou
studi
show
oper
poorli
doublestrand
region
rna
substrat
vitro
line
found
abl
catalyz
degrad
rna
substrat
deriv
left
arm
panel
b
lane
lack
secondari
structur
furthermor
effici
degrad
singlestrand
linear
poli
ra
oligo
vitro
panel
b
lane
confirm
recombin
protein
use
assay
enzymat
activ
control
rnase
unabl
degrad
poli
ra
cleav
rna
string
end
pyrimidin
rc
u
residu
panel
b
lane
sinc
rna
substrat
radiolabel
pattern
degrad
intermedi
gener
consist
exoribonucleas
activ
panel
b
lane
collect
vitro
data
indic
host
cofactor
may
requir
coordin
observ
effici
hbv
rna
degrad
cell
summari
report
function
exoribonucleas
degrad
hbv
rna
serv
intrins
host
restrict
factor
hbv
infect
select
hbv
rna
determin
uniqu
viral
ribonucleotid
string
shape
stemloop
structur
exist
hbv
rna
speci
directli
bind
lower
stem
ctermin
exo
iii
domain
proteinrna
interact
possibl
assist
host
cofactor
lead
major
antivir
action
enzymat
activ
depend
hbv
rna
degrad
subsequ
viral
protein
translat
dna
replic
inhibit
fig
addit
certain
circumst
enzymat
activ
could
inhibit
ie
mutant
bind
may
remain
antivir
compet
bind
viral
polymeras
block
subsequ
pgrna
encapsid
revers
transcript
well
document
acut
hbv
infect
activ
host
tcell
respons
play
pivot
role
clear
viru
hepatocyt
via
noncytolyt
mechan
larg
attribut
antivir
proinflammatori
cytokin
produc
infiltr
immun
cell
date
avail
immunotherapi
treatment
chronic
hepat
b
besid
serv
immunomodulatori
agent
regul
host
adapt
immun
hbv
intracellular
antivir
activ
mediat
array
isg
search
intrahepat
isg
associ
immun
clearanc
hbv
grow
bodi
evid
impli
may
involv
ifn
mediat
inhibit
hbv
includ
upregul
hbv
transgen
mous
hepatocyt
cell
line
hbv
replic
inhibit
ifn
elev
level
viral
clearanc
phase
acut
hbv
infect
chimpanze
upregul
chronic
hepat
b
patient
respond
well
therapi
consist
find
found
highli
induc
hepatocyt
vitro
three
type
interferon
play
signific
role
elicit
antivir
effect
hbv
infect
replic
fig
consid
hbv
rna
essenti
genet
compon
viral
replic
gene
express
life
cycl
upregul
express
cytokin
elimin
hbv
rna
econom
effici
way
host
defens
mechan
addit
studi
also
expand
antivir
spectrum
dna
viru
consid
current
hbv
therapi
nucleosid
analogu
ineffect
viral
protein
express
effici
promot
hbeag
hbsag
seroconvers
thu
envis
antivir
therapi
could
develop
futur
reduc
viremia
antigenemia
chb
patient
cellular
function
remain
elus
previous
shown
inhibit
number
rna
virus
includ
vsv
influenza
virus
picornavirus
emcv
hav
flavivirus
hcv
wnv
bovin
viral
diarrhea
viru
bvdv
previous
report
antivir
effect
rna
virus
depend
exonucleas
activ
though
degrad
viral
rna
directli
catalyz
experiment
confirm
howev
rna
degrad
might
mechan
antivir
action
instanc
zhou
et
al
found
promot
degrad
replicationdefect
hcv
rna
genom
cell
qu
et
al
observ
inhibit
influenza
viru
replic
interact
viral
nucleoprotein
furthermor
rna
virus
suscept
sever
acut
respiratori
syndrom
coronaviru
sarscov
shown
resist
cell
cultur
indic
viral
specif
factor
determin
antivir
specif
clearli
demonstr
abl
promot
hbv
rna
degrad
cell
cultur
effect
depend
protein
exonucleas
activ
fig
prepar
manuscript
leong
et
al
also
report
inhibit
hbv
replic
cell
cultur
hydrodynam
inject
mous
liver
via
exoribonucleasedepend
degrad
viral
rna
larg
consist
result
studi
touch
molecular
mechan
select
target
hbv
rna
studi
map
sequenc
element
respons
hbv
rna
degrad
region
hbv
rna
genom
fig
confirm
direct
bind
emsa
assay
fig
best
knowledg
first
report
reveal
rna
sequencestructurespecif
recognit
requir
degrad
viral
rna
substrat
characterist
make
mechanist
distinct
rnase
l
wellknown
antivir
isg
upon
activ
nonspecif
destroy
viral
cellular
rna
cell
regard
repres
novel
class
cellular
antivir
isg
reminisc
sequencespecif
antivir
rnai
system
target
viral
rna
directli
without
help
small
guid
rna
hbv
rna
typic
mrna
produc
host
rna
polymeras
ii
possess
cap
poli
tail
similar
cellular
mrna
despit
sequenc
differ
host
mrna
uniqu
structur
signatur
hbv
rna
serv
pgrna
packag
signal
prime
site
interact
viral
polymeras
thu
conceiv
recogn
nonself
target
initi
antivir
function
line
recent
report
host
innat
sensor
rigi
bind
trigger
product
addit
determin
bottom
lower
stem
minim
respons
element
remov
sequenc
hbv
rna
made
lose
bind
activ
vitro
hbv
rna
reduct
effect
cell
cultur
fig
sequenc
structur
inform
could
serv
consensu
motif
predict
rna
element
virus
perhap
host
rna
well
despit
act
host
antivir
factor
potenti
function
regul
host
cellular
function
remain
obscur
sinc
target
viral
mrna
destabil
plausibl
may
also
alter
stabil
certain
cellular
mrna
regul
host
gene
express
exampl
observ
enhanc
hbv
promot
activ
may
due
upregul
host
transcript
factor
requir
promot
activ
downregul
neg
regul
promot
fig
notion
also
support
previou
observ
antivir
effect
hcv
inhibit
hcv
rna
stabil
translat
indic
might
degrad
mrna
host
factor
essenti
hcv
replic
interestingli
consid
favor
short
rna
stemloop
structur
affin
bind
also
possibl
potenti
target
host
microrna
mirna
precursor
primirna
premirna
long
noncod
rna
lncrna
may
contain
stemloop
structur
regul
mirna
process
lncrna
stabil
respect
addit
known
ifn
regul
cellular
gene
express
primarili
mrna
level
possibl
ifninduc
rnase
may
partli
mediat
action
ifn
alter
host
mrna
stabil
current
conduct
rnaseq
analysi
search
potenti
host
rna
substrat
three
predict
exonucleas
domain
exo
iiii
exo
ii
valid
major
enzymat
domain
found
catalyt
site
exo
ii
essenti
hbv
rna
reduct
mutant
retain
rna
bind
activ
inhibit
hbv
pgrna
encapsid
compet
bind
hbv
polymeras
fig
although
antivir
effect
may
minor
context
wildtyp
hbv
rna
degrad
serendipit
find
led
us
discov
bind
properti
hbv
rna
fig
interestingli
minim
bind
site
locat
bottom
stemloop
fig
dispens
hbv
polymeras
bind
indic
inhibit
polymeras
bind
due
interactioninduc
steric
hindranc
andor
conform
shift
addit
domain
bind
map
exo
iii
region
fig
suggest
substrat
interact
degrad
domain
separ
consist
report
crystal
structur
analysi
predict
amino
acid
composit
exo
ii
unfavor
rna
bind
howev
classic
rna
bind
motif
found
exo
iii
domain
entir
sequenc
comput
predict
http
shown
interact
host
small
nucleolar
rna
snorna
also
stemloop
indic
may
possess
novel
bind
motif
kind
doubl
strand
rna
secondari
structur
includ
hbv
previous
identifi
host
zincfing
antivir
protein
zap
restrict
factor
hbv
promot
hbv
rna
degrad
zap
exert
antivir
activ
hbv
certain
featur
similar
specif
zap
interact
hbv
rna
rna
degrad
manner
sinc
zap
possess
nucleas
activ
initi
hypothesi
zap
might
recruit
rna
degrad
howev
coimmunoprecipit
assay
reveal
detect
associ
zap
absenc
presenc
hbv
rna
fig
indic
zap
work
independ
target
hbv
antivir
function
host
cell
evolv
multipl
mechan
recogn
nonself
hbv
antivir
sens
signal
worth
note
exoribonucleas
locat
near
end
hbv
rna
addit
copi
precor
mrna
pgrna
therefor
specul
bind
initi
substrat
sens
step
rna
topolog
chang
andor
transloc
may
requir
subsequ
rna
degrad
end
hbv
rna
addit
sinc
could
singlehandedli
degrad
poli
ra
oligo
vitro
degrad
assay
fig
whether
poli
specif
ribonucleas
parn
requir
remov
poli
tail
hbv
mrna
degrad
reaction
await
investig
interestingli
vitro
rna
degrad
assay
demonstr
effici
degrad
singlestrand
rna
rna
substrat
fig
indic
addit
host
factor
like
rna
helicas
requir
unwind
doublestrand
region
catalyz
rna
degrad
therefor
embark
identif
cofactor
degradesom
complex
proteom
approach
taken
togeth
phenotyp
mechanist
character
antivir
effect
hbv
replic
present
current
studi
shed
light
biolog
virushost
interact
also
provid
insight
develop
ribonucleasebas
antivir
therapi
treatment
hepat
b
human
hepatocytederiv
cell
maintain
medium
mediatech
supplement
fetal
bovin
serum
uml
penicillin
streptomycin
cell
maintain
way
addit
tetracyclin
tet
initi
hbv
replic
cell
tet
withdrawn
cultur
medium
cell
cultur
indic
time
primari
human
hepatocyt
purchas
triangl
research
lab
cultur
accord
supplier
protocol
cell
maintain
previous
describ
endogen
express
cell
stabli
knock
transduct
shrna
lentivir
particl
santa
cruz
biotechnolog
per
manufactur
direct
transduc
cell
select
puromycin
antibioticsresist
cell
pool
expand
cell
line
name
control
known
cell
line
gener
transduct
control
shrna
lentivir
particl
santa
cruz
biotechnolog
design
shcontrol
control
sirna
sirna
purchas
santa
cruz
biotechnolog
transient
knock
experi
recombin
human
purchas
pbl
biomed
laboratori
hbv
genotyp
subtyp
ayw
replic
compet
plasmid
pcmvhbv
transcript
viral
pgrna
govern
authent
hbv
core
promot
human
cytomegaloviru
immediateearli
cmvie
promot
respect
describ
previous
plasmid
ptrehbvd
transcrib
pgrna
control
tetracyclineinduc
cmv
promot
previous
use
togeth
plasmid
ptetoff
clontech
gener
stabl
cell
line
hbv
plasmid
mutat
start
codon
atg
ata
core
protein
open
read
frame
orf
provid
dr
robert
lanford
hbv
plasmid
start
codon
mutat
atg
acg
pol
orf
abolish
pol
express
without
chang
amino
acid
sequenc
overlap
core
protein
plasmid
contain
start
codon
mutat
core
atg
ctg
pol
atg
acg
orf
pcmvhbv
backbon
block
express
core
pol
respect
bear
substitut
revers
transcriptas
domain
hbv
pol
gene
block
dna
synthesi
still
allow
pgrna
encapsid
provid
dr
jianm
hu
plasmid
pcmvflagpol
express
hbv
pol
three
copi
flag
epitop
n
terminu
cmv
promot
provid
dr
wangshick
ryu
use
cell
transfect
plasmid
anoth
hbv
polymeras
express
construct
express
hbv
polymeras
hp
promot
pcdna
backbon
provid
dr
jianm
hu
use
vitro
translat
plasmid
plm
express
hbv
surfac
mrna
control
authent
viral
surfac
promot
provid
dr
youhua
xie
plasmid
pm
express
hbv
surfac
mrna
control
cmv
promot
construct
remov
four
nucleotid
bottom
right
arm
lower
stem
sequenc
pm
pgrna
intern
delet
clone
termin
redund
tr
delet
clone
luciferas
report
plasmid
encpluc
encptrluc
encpluctr
encptrluctr
construct
previous
plasmid
express
ntermin
flagtag
wildtyp
control
cmv
promot
describ
previous
deriv
delet
code
sequenc
exoiii
domain
plasmid
express
hatag
construct
sitedirect
mutagenesi
kit
new
england
biolab
replac
flagtag
sequenc
f
hatag
plasmid
hazap
express
hatag
zap
protein
eukaryot
cell
cell
seed
collagen
coat
plate
transfect
indic
plasmid
sirna
lipofectamin
life
technolog
accord
manufactur
direct
cell
transfect
promot
report
plasmid
plu
vector
express
gene
interest
lipofectamin
prlcmv
renilla
luciferas
report
plasmid
cotransfect
normal
transfect
effici
transfect
empti
control
plasmid
ad
ensur
transfect
receiv
amount
total
dna
ngwell
three
day
transfect
luciferas
activ
measur
dual
luciferas
assay
kit
promega
biotek
synergi
multimod
reader
shcontrol
cell
spinocul
hbv
virion
particl
deriv
cell
viru
genom
equival
vge
cell
accord
publish
protocol
six
day
post
infect
cell
fix
subject
hbcag
immunofluoresc
describ
previous
total
cellular
rna
hirt
dna
cytoplasm
encapsid
hbv
pgrna
core
dna
extract
describ
previous
hbv
rna
qpcr
assay
dnase
itreat
total
cellular
rna
use
gener
cdna
superscript
iii
revers
transcriptas
life
technolog
realtim
pcr
perform
sybr
green
master
roch
lightcycl
system
roch
detect
hbv
total
rna
use
hbv
specif
primer
target
overlap
region
hbv
rna
speci
forward
primer
revers
primer
rel
express
level
hbv
rna
normal
sampl
hbv
rna
northern
blot
analysi
total
cellular
rna
encapsid
pgrna
sampl
resolv
agaros
gel
contain
formaldehyd
transfer
onto
hybondxl
membran
ge
healthcar
dna
southern
blot
analysi
hirt
dna
hbv
core
dna
sampl
resolv
electrophoresi
agaros
gel
blot
onto
hybondxl
membran
membran
probe
either
cimmol
perkin
elmer
label
plusstrandspecif
northern
blot
hybrid
minusstrandspecif
southern
blot
hybrid
fulllength
hbv
riboprob
expos
phosphorimag
screen
hybrid
signal
quantifi
quantityon
softwar
biorad
cytoplasm
hbv
capsid
particl
resolv
nativ
agaros
gel
electrophoresi
transfer
onto
nitrocellulos
membran
follow
capsid
enzym
immunoassay
assay
eia
use
antibodi
core
dako
situ
hbv
dna
hybrid
describ
previous
whole
cell
lysat
sampl
prepar
laemmli
buffer
resolv
gradient
sdspage
protein
transfer
onto
immobilon
pvdffl
membran
millipor
membran
block
western
breez
block
buffer
life
technolog
probe
antibodi
flagtag
sigma
clone
hatag
covanc
clone
millipor
bound
antibodi
reveal
irdy
secondari
antibodi
immunoblot
signal
visual
quantifi
licor
odyssey
system
hbeag
hbsag
cultur
fluid
detect
hbeag
elisa
kit
autobio
diagnost
hbsag
elisa
kit
abazym
follow
manufactur
instruct
cell
cotransfect
control
vector
flagtag
wildtyp
mutant
mm
dish
maintain
day
harvest
cell
lyse
ice
cell
lysi
buffer
contain
mm
trishcl
ph
mm
edta
mm
nacl
sucros
rnasin
plu
rnase
inhibitor
promega
centrifug
remov
cell
debri
clarifi
cell
lysat
incub
ezview
red
antiha
antiflag
affin
gel
sigmaaldrich
h
gentl
rotat
bead
spun
resuspend
gentli
rins
buffer
mm
trishcl
ph
mm
edta
mm
nacl
rnasin
plu
rnase
inhibitor
three
time
pellet
bead
subject
rna
extract
trizol
protein
sampl
prepar
laemmli
buffer
immunoprecipit
protein
hbv
rna
analyz
western
blot
northern
blot
assay
respect
term
rna
bind
competit
assay
hbv
pol
cotransfect
either
control
vector
pcmvflagpol
increas
amount
indic
fig
flag
ha
immunoprecipit
perform
protocol
describ
associ
hbv
rna
visual
via
northern
blot
use
radiolabel
hbv
rna
specif
riboprob
orf
wildtyp
mutant
pcr
amplifi
plasmid
respect
clone
prset
prokaryot
express
vector
thermo
fisher
scientif
promot
bamhi
ecori
site
gener
plasmid
express
histag
delet
mutant
deriv
use
sitedirect
mutagenesi
kit
new
england
biolab
per
manufactur
protocol
protein
express
vector
transform
escherichia
coli
plyss
compet
cell
promega
cell
propag
aerat
l
sob
broth
presenc
ampicillin
follow
ad
mm
iptg
induc
protein
express
hour
induct
recombin
protein
detect
via
sdspage
coomassi
stain
compar
uninduc
control
sampl
aforement
histag
protein
express
bacteria
purifi
use
denatur
condit
briefli
bacteri
pellet
resuspend
naphosph
trishcl
guanidinehcl
ph
fresh
mm
pmsf
stir
h
lyse
cell
solubil
protein
denatur
condit
cell
extract
centrifug
min
supernat
fraction
contain
solubl
protein
incub
batch
perfectpro
ninta
agaros
h
room
temperatur
resin
wash
naphosph
trishcl
guanidinehcl
ph
two
time
naphosph
trishcl
guanidinehcl
ph
addit
mm
imidazol
resin
load
suppli
purif
column
protein
elut
naphosph
trishcl
guanidinehcl
ph
mm
imidazol
mm
pmsf
elut
protein
dialyz
three
chang
mm
nacl
glycerol
freshli
ad
mm
dtt
mm
pmsf
solubl
protein
concentr
pierc
concentr
cutoff
thermo
scientif
biorad
bradford
protein
assay
coomassi
stain
use
measur
concentr
puriti
protein
synthet
hbv
rna
fragment
shown
tabl
dissolv
buffer
depc
treat
concentr
denatur
water
bath
min
follow
slow
cool
room
temperatur
rna
anneal
secondari
structur
format
hbv
rna
endlabel
polynucleotid
kinas
new
england
biolab
purifi
quick
spin
sephadex
column
roch
indic
amount
protein
incub
ng
hbv
rna
presenc
mm
hepe
mm
kcl
mm
dtt
mgml
bsa
glycerol
poli
didc
min
form
nucleoprotein
complex
monoclon
antipolyhistidin
antibodi
clone
sigma
use
supershift
hbv
complex
cold
unlabel
hbv
rna
use
compet
bind
protein
ng
radiolabel
hbv
nucleoprotein
complex
separ
nativ
page
v
gel
buffer
contain
mm
tri
mm
boric
acid
vv
glycerol
h
cold
room
gel
fix
acet
acid
methanol
dri
visual
autoradiographi
express
vector
use
express
tag
hbv
pol
tnt
coupl
reticulocyt
lysat
system
promega
follow
manufactur
instruct
control
ivt
reaction
done
empti
vector
invitrogen
one
microlit
control
ivt
sampl
mix
pradiolabel
rna
tmnk
rna
bind
buffer
mm
tri
ph
mm
mm
nacl
mm
kcl
mm
dtt
previous
use
hbv
pol
rna
bind
reaction
halt
proteas
inhibitor
cocktail
thermofish
rnasin
rnase
inhibitor
promega
yeast
trna
ad
bind
reaction
incub
h
pol
bind
complex
reveal
emsa
describ
ribonucleas
assay
perform
accord
previous
publish
reaction
condit
briefli
synthet
rna
oligo
tabl
pretreat
describ
allow
secondari
structur
format
purif
label
ng
radiolabel
rna
substrat
incub
rnase
new
england
biolab
purifi
recombin
nucleas
assay
buffer
mm
hepeskoh
ph
glycerol
mm
nacl
mm
triton
mm
dtt
min
reaction
stop
formamid
dye
solut
mixtur
heat
min
fraction
novex
tbeurea
denatur
polyacrylamid
gel
thermofish
gel
dri
subject
autoradiographi
